Boralex Inc.
BRLXF
$19.88
-$0.6174-3.01%
| Weiss Ratings | BRLXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | C | |||
| Rating Factors | BRLXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Fair | |||
| Growth Index | Fair | |||
| Efficiency Index | Fair | |||
| Solvency Index | Good | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | BRLXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.53 | |||
| Price History | BRLXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -4.93% | |||
| 30-Day Total Return | 9.77% | |||
| 60-Day Total Return | -1.21% | |||
| 90-Day Total Return | -7.62% | |||
| Year to Date Total Return | -1.21% | |||
| 1-Year Total Return | -5.29% | |||
| 2-Year Total Return | -36.10% | |||
| 3-Year Total Return | -40.30% | |||
| 5-Year Total Return | 11.49% | |||
| 52-Week High % Change | -26.56% | |||
| 52-Week Low % Change | 26.46% | |||
| Price | BRLXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $27.07 | |||
| 52-Week Low Price | $15.72 | |||
| 52-Week Low Price (Date) | Jan 22, 2025 | |||
| 52-Week High Price (Date) | Jun 10, 2024 | |||
| Valuation | BRLXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 2.04B | |||
| Enterprise Value | 4.93B | |||
| Price/Earnings (TTM) | 77.93 | |||
| Earnings Per Share (TTM) | 0.26 | |||
| Earnings Per Share Growth | -53.41% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 3.28 | |||
| Price/Book (Q) | 1.84 | |||
| Enterprise Value/Revenue (TTM) | 7.91 | |||
| Price | $19.88 | |||
| Enterprise Value/EBITDA (TTM) | 13.40 | |||
| Enterprise Value/EBIT | 29.20 | |||
| Market Cap Category | Mid Cap | |||
| Dividends and Shares | BRLXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 102.77M | |||
| Dividend Yield | 2.38% | |||
| Div. Per Share (Most Recent) | $0.12 | |||
| Dividend Per Share (TTM) | $0.47 | |||
| Payout Ratio (TTM) | 182.91% | |||
| Dividend Per Share (Most Recent) | $0.12 | |||
| Company Info | BRLXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 819 363 6363 | |||
| Address | 36 Lajeunesse Street Kingsey Falls, QC J0A 1B0 | |||
| Website | www.boralex.com | |||
| Country | Canada | |||
| Year Founded | 1982 | |||
| Profitability | BRLXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 27.09% | |||
| Profit Margin | 4.35% | |||
| Management Effectiveness | BRLXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 2.05% | |||
| Return on Equity | 3.73% | |||
| Income Statement | BRLXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 596.50M | |||
| Total Revenue (TTM) | 622.78M | |||
| Revenue Per Share | $6.06 | |||
| Gross Profit (TTM) | 478.11M | |||
| EBITDA (TTM) | 367.68M | |||
| EBIT (TTM) | 168.71M | |||
| Net Income (TTM) | 27.14M | |||
| Net Income Avl. to Common (TTM) | 27.14M | |||
| Total Revenue Growth (Q YOY) | -28.91% | |||
| Earnings Growth (Q YOY) | -103.35% | |||
| EPS Diluted (TTM) | 0.26 | |||
| EPS Diluted Growth (Q YOY) | -142.03% | |||
| Balance Sheet | BRLXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 411.44M | |||
| Cash Per Share (Q) | $4.00 | |||
| Total Current Assets (Q) | 641.49M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 1.41B | |||
| Current Ratio (Q) | 0.956 | |||
| Book Value Per Share (Q) | $10.83 | |||
| Total Assets (Q) | 5.28B | |||
| Total Current Liabilities (Q) | 670.68M | |||
| Total Debt (Q) | 3.00B | |||
| Total Liabilities (Q) | 3.88B | |||
| Total Common Equity (Q) | 1.11B | |||
| Cash Flow | BRLXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -419.11M | |||
| Cash from Financing (TTM) | 341.17M | |||
| Net Change in Cash (TTM) | 80.12M | |||
| Levered Free Cash Flow (TTM) | 79.60M | |||
| Cash from Operations (TTM) | 158.69M | |||
